Voyager Acquisition issues 2.39M warrant shares for Veraxa Biotech acquisition
Voyager Acquisition Corp. filed a warrant agreement for 2,391,305 ordinary shares of Veraxa Biotech Holding AG with a four-year exercise window. The warrant structure includes exercise price provisions and potential debt offset mechanisms tied to a Senior Secured Note, facilitati
View filing at SEC.gov →